Tokyo Tape
Sign in
← PeptiDream

Quarterly report · Q1

4587.TEDINET S100QQKF
Period2023-01-01 → 2023-03-31
Filed2023-05-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed

Amended by S100S6T6 (2023-11-09).

Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥5.0bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Revenue¥26.9bn2022-01-01 → 2022-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥420m2022-01-01 → 2022-03-31Cons.Revenue IFRS
Operating income−¥267m2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Operating income−¥1.2bn2022-01-01 → 2022-03-31Cons.Operating profit loss IFRS
Profit before tax−¥400m2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Profit before tax¥6.7bn2022-01-01 → 2022-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥1.1bn2022-01-01 → 2022-03-31Cons.Profit loss before tax IFRS
Net income (owners)−¥249m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥7.6bn2022-01-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥829m2022-01-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income−¥249m2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Net income¥7.6bn2022-01-01 → 2022-12-31Cons.Profit loss IFRS (5-year summary)
Net income−¥829m2022-01-01 → 2022-03-31Cons.Profit loss IFRS
Total assets¥59.8bnat 2023-03-31Cons.Assets IFRS
Total assets¥63.9bnat 2022-12-31Cons.Assets IFRS
Total assets¥52.9bnat 2022-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥28.0bnat 2023-03-31Cons.Liabilities IFRS
Total liabilities¥31.8bnat 2022-12-31Cons.Liabilities IFRS
Net assets / equity¥31.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥32.0bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥24.7bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥25.4bnat 2021-12-31dCons.Equity IFRS
Equity (owners)¥31.8bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥32.0bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥24.7bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥11.6bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥5.2bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥10.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥11.7bnat 2021-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥7.7bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥83m2022-01-01 → 2022-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥8m2022-01-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥381m2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥27.4bn2022-01-01 → 2022-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥23.7bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥1.1bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥20.8bn2022-01-01 → 2022-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥22.2bn2022-01-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-1.922023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥58.192022-01-01 → 2022-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-6.392022-01-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-1.922023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥58.142022-01-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-6.392022-01-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio53.2%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.2%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio46.6%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 13
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥3m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥3m
jpcrp040300-q1r_E27486-000Drug Discovery And Development Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥978m
jpcrp040300-q1r_E27486-000Drug Discovery And Development Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥978m
jpcrp040300-q1r_E27486-000Drug Discovery And Development Businessreportable segmentsegment profit2023-01-01 → 2023-03-31−¥381m
jpcrp040300-q1r_E27486-000Radiopharmaceuticals Businessreportable segmentrevenue2023-01-01 → 2023-03-31¥4.0bn
jpcrp040300-q1r_E27486-000Radiopharmaceuticals Businessreportable segmentrevenue external2023-01-01 → 2023-03-31¥4.0bn
jpcrp040300-q1r_E27486-000Radiopharmaceuticals Businessreportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥3m
jpcrp040300-q1r_E27486-000Radiopharmaceuticals Businessreportable segmentsegment profit2023-01-01 → 2023-03-31¥136m
—segment totalrevenue2023-01-01 → 2023-03-31¥5.0bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥5.0bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥3m
—segment totalsegment profit2023-01-01 → 2023-03-31−¥244m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 486
ItemContextValueUnit
Cost of sales IFRSPrior1YTDDuration495544000JPY
Cost of sales IFRSCurrentYTDDuration2814443000JPY
Gross profit IFRSPrior1YTDDuration-76018000JPY
Gross profit IFRSCurrentYTDDuration2149026000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration695452000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration1698672000JPY
Research and development expenses IFRSPrior1YTDDuration394189000JPY
Research and development expenses IFRSCurrentYTDDuration708103000JPY
Other income IFRSPrior1YTDDuration－JPY
Other income IFRSCurrentYTDDuration3746000JPY
Other expenses IFRSPrior1YTDDuration1000000JPY
Other expenses IFRSCurrentYTDDuration12583000JPY
Operating profit loss IFRSPrior1YTDDuration-1166661000JPY
Operating profit loss IFRSCurrentYTDDuration-266586000JPY
Finance income IFRSPrior1YTDDuration102855000JPY
Finance income IFRSCurrentYTDDuration5663000JPY
Finance costs IFRSPrior1YTDDuration－JPY
Finance costs IFRSCurrentYTDDuration104728000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration-59959000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration-34262000JPY
Profit loss before tax IFRSPrior1YTDDuration-1123765000JPY
Profit loss before tax IFRSCurrentYTDDuration-399914000JPY
Income tax expense IFRSPrior1YTDDuration-294469000JPY
Income tax expense IFRSCurrentYTDDuration-151112000JPY
Profit loss IFRSPrior1YTDDuration-829296000JPY
Profit loss IFRSCurrentYTDDuration-248801000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration-829296000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration-248801000JPY
Profit loss IFRSPrior1YTDDuration-829296000JPY
Profit loss IFRSCurrentYTDDuration-248801000JPY
Basic earnings loss per share IFRSPrior1YTDDuration-6.39
Basic earnings loss per share IFRSCurrentYTDDuration-1.92
Diluted earnings loss per share IFRSPrior1YTDDuration-6.39
Diluted earnings loss per share IFRSCurrentYTDDuration-1.92
Profit loss IFRSPrior1YTDDuration-829296000JPY
Profit loss IFRSCurrentYTDDuration-248801000JPY
Financial assets measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration147390000JPY
Financial assets measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration14334000JPY
Total of items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration147390000JPY
Total of items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration14334000JPY
Other comprehensive income IFRSPrior1YTDDuration147390000JPY
Other comprehensive income IFRSCurrentYTDDuration14334000JPY
Comprehensive income IFRSPrior1YTDDuration-681906000JPY
Comprehensive income IFRSCurrentYTDDuration-234467000JPY
Comprehensive income attributable to owners of parent IFRSPrior1YTDDuration-681906000JPY
Comprehensive income attributable to owners of parent IFRSCurrentYTDDuration-234467000JPY
Comprehensive income IFRSPrior1YTDDuration-681906000JPY
Comprehensive income IFRSCurrentYTDDuration-234467000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember3956738000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember4452358000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-12-31pass rounding
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2022-01-01/2022-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass